Phio Pharmaceuticals Appoints David Deming as Lead Independent Director

Reuters10-31
<a href="https://laohu8.com/S/PHIO">Phio Pharmaceuticals</a> Appoints David Deming as Lead Independent Director

Phio Pharmaceuticals Corp. has announced the appointment of David H. Deming as Lead Independent Director of its Board of Directors. Deming, who joined the board in February 2025, brings more than 30 years of experience in investment banking and asset management, including over 27 years at JP Morgan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 272731) on October 31, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment